Skip to Main Content
Table 2.

Clinical data

n (%)
No. patients 110 (100) 
Age  
    Median (range), y 61 (16-93) 
Sex  
    Female/male 52/58 (47/53) 
Karnofsky performance status <90% 7 (6.3) 
Properties of uveal melanoma  
    Largest tumor diameter (>14 mm)* 62 (56) 
    Ciliary body infiltration 40 (36) 
    Extraocular growth 10 (9) 
Positive results of RT-PCR  
    Tyrosinase 6 (55) 
    MelanA/MART1 6 (5.5) 
    PCR (tyrosinase or MelanA/MART111 (10) 
Follow-up interval from time of blood sampling  
    Median (range), mo 22 (4-84) 
n (%)
No. patients 110 (100) 
Age  
    Median (range), y 61 (16-93) 
Sex  
    Female/male 52/58 (47/53) 
Karnofsky performance status <90% 7 (6.3) 
Properties of uveal melanoma  
    Largest tumor diameter (>14 mm)* 62 (56) 
    Ciliary body infiltration 40 (36) 
    Extraocular growth 10 (9) 
Positive results of RT-PCR  
    Tyrosinase 6 (55) 
    MelanA/MART1 6 (5.5) 
    PCR (tyrosinase or MelanA/MART111 (10) 
Follow-up interval from time of blood sampling  
    Median (range), mo 22 (4-84) 
*

n = 105.

n = 98.

Close Modal

or Create an Account

Close Modal
Close Modal